SeQuent® Please OTW

Peripheral drug coated balloon catheter


SeQuent® Please OTW features an optimized and clinically proven drug-coating technology which facilitates the safe and effective treatment of patients with peripheral arterial disease (PAD) in above and below the knee indications. [1, 2]

Controlled and effective drug dosage of Paclitaxel

  • Drug Dosage 3μg/mm2
  • Effective reduction of TLR compared to uncoated balloons
  • Homogeneous coating even in the balloon folds exceeding distal and proximal markers

Resveratrol: A hydrophilic excipient

  • Naturally occurring, plant-based substance
  • Acts as hydrophilic spacer and makes the Paclitaxel bioavailable
  • Enables controlled drug transfer into vessel wall

Mechanically resistant coating [3]

  • Low drug loss in simulated use (<2 %)
  • High available drug dose at inflation
  • Designed for technical success
  • Kink resistant shaft
  • Low crossing profile

[1] Albrecht T et al. Cardiovasc Intervent Radiol. 2018 Jul;41(7):1008-1014

[2] Langhoff R et al. Angiology. 2021 Mar 29:3319721997314.

[3] Data on file at B. Braun.


  • Please enable marketing cookies to enable Youtube Video

    Live case Klinikum Arnsberg

    Intervention SFA right with SeQuent® Please OTW & VascuFlex® Multi-LOC

  • Please enable marketing cookies to enable Youtube Video

    Interview with Dr. Klaus Amendt by Vascular News

    Dr. Amendt explained why the multiple stent system is a unique andexciting treatment option, and which future projects are planned with the VasuFlex® Multi-LOC system.